OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
January 16, 2023
The members reviewed the measures to minimize the risk of serious side effects associated with Janus kinase (JAK) inhibitors used to treat several chronic inflammatory disorders.
October 02, 2022
There are many benefits of employing a reformulation strategy, but companies must also overcome a variety of challenges too.
September 02, 2022
While a variety of innovations have already impacted the drug delivery landscape, improving sustainability and having the ability to make smaller volumes of drug products still require work.
March 18, 2022
Sanofi is collaborating with Blackstone Life Sciences to accelerate the development of a treatment for multiple myeloma.
October 02, 2021
The intranasal route of administration is showing clinical promise, particularly for COVID-19, but there are multiple hurdles to overcome to ensure successful formulation.
April 02, 2021
The inhaled route of administration for biologics is experiencing renewed interest, particularly in light of the COVID-19 pandemic.
July 08, 2020
The European Commission has approved Lynparza (olaparib) for use in patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer within the European Union.
May 04, 2020
Kindeva Drug Delivery plans capital investment and jobs growth.
March 01, 2019
The technology uses a silica nanoparticle to deliver vaccines and cancer treatments.
September 19, 2018
The drug particle engineering and nanotechnology company offers a nanotechnology platform that can revive failed drugs in the pharma pipeline.